- Home
- KEP vs DGX Comparison
KEP vs DGX Comparison
Compare KEP & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEP
- DGX
- Stock Information
- Founded
- KEP 1961
- DGX 1967
- Country
- KEP South Korea
- DGX United States
- Employees
- KEP N/A
- DGX N/A
- Industry
- KEP Electric Utilities: Central
- DGX Medical Specialities
- Sector
- KEP Utilities
- DGX Health Care
- Exchange
- KEP Nasdaq
- DGX Nasdaq
- Market Cap
- KEP 17.8B
- DGX 20.5B
- IPO Year
- KEP N/A
- DGX 1996
- Fundamental
- Price
- KEP $17.02
- DGX $187.31
- Analyst Decision
- KEP
- DGX Buy
- Analyst Count
- KEP 0
- DGX 15
- Target Price
- KEP N/A
- DGX $194.07
- AVG Volume (30 Days)
- KEP 442.4K
- DGX 1.2M
- Earning Date
- KEP 11-14-2025
- DGX 10-21-2025
- Dividend Yield
- KEP 0.29%
- DGX 1.71%
- EPS Growth
- KEP 122.09
- DGX 14.49
- EPS
- KEP 9.13
- DGX 8.51
- Revenue
- KEP $69,245,360,188.00
- DGX $10,850,000,000.00
- Revenue This Year
- KEP $5.26
- DGX $12.37
- Revenue Next Year
- KEP $2.04
- DGX $3.51
- P/E Ratio
- KEP $3.57
- DGX $21.96
- Revenue Growth
- KEP 5.27
- DGX 13.74
- 52 Week Low
- KEP $6.68
- DGX $148.70
- 52 Week High
- KEP $17.00
- DGX $197.55
- Technical
- Relative Strength Index (RSI)
- KEP 65.07
- DGX 59.57
- Support Level
- KEP $16.29
- DGX $184.50
- Resistance Level
- KEP $16.90
- DGX $190.47
- Average True Range (ATR)
- KEP 0.28
- DGX 4.28
- MACD
- KEP 0.07
- DGX 1.10
- Stochastic Oscillator
- KEP 95.77
- DGX 77.53
About KEP Korea Electric Power Corporation
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.